Sign In
Buy IHE
$100.51
-1.71 (-1.67%)
At Close: Jul 10, 2026
IHE vs. IBB: Which iShares Healthcare ETF Is the Better Buy?
06:41am, Friday, 10'th Jul 2026
The iShares U.S. Pharmaceuticals ETF (IHE) offers a lower expense ratio and a significantly higher dividend yield than the iShares Biotechnology ETF (IBB). IBB offers broader diversification, with 248
IHE vs. PJP: Which Pharmaceutical ETF Is the Better Buy for Investors?
11:16am, Sunday, 05'th Jul 2026
The iShares U.S. Pharmaceuticals ETF (IHE) charges a lower expense ratio and pays a higher dividend than the Invesco Pharmaceuticals ETF (PJP). IHE is heavily concentrated in its two largest holdings,
Big Pharma's Looming Patent Cliff Period And How It Is Trying To Address It
05:00pm, Monday, 29'th Jun 2026
Big pharma's patent cliff risk is somewhat overstated, as layered IP and litigation often extend exclusivity beyond headline expiries. Incremental innovation—new formulations, improved delivery, and
Is iShares Pharma ETF (IHE) or SPDR's Biotech ETF (XBI) the Better Long-Term Buy for Investors?
03:46pm, Wednesday, 17'th Jun 2026
iShares U.S. Pharmaceuticals ETF offers a significantly higher dividend yield and lower volatility than State Street SPDR S&P Biotech ETF. While State Street SPDR S&P Biotech ETF delivered stronger 1-
Healthcare ETFs: From Broad Exposure to Big Breakthroughs
07:14am, Thursday, 11'th Jun 2026
With AI and space dominating many of the market's most popular investment themes, it can be difficult to find differentiated opportunities. Healthcare is often viewed as one of the more defensive sect
iShares U.S. Pharmaceuticals ETF Tops Simplify Health Care ETF Returns
02:17pm, Wednesday, 10'th Jun 2026
iShares U.S. Pharmaceuticals ETF provides more cost-efficient access to the healthcare sector with a lower expense ratio and a higher dividend yield Simplify Health Care ETF employs an active manageme
Inside the GLP-1 Boom: ETF Picks for the Obesity Drug Market
01:01pm, Wednesday, 10'th Jun 2026
GLP-1 drugs are reshaping healthcare and consumer markets. These ETFs offer targeted exposure to the booming obesity-drug trend.
Middle East Erupts Again: Buy these Healthcare ETFs Before the Next Strike
11:01am, Tuesday, 09'th Jun 2026
Healthcare ETFs are gaining attention as Middle East tensions and market volatility boost demand for defensive sectors.
GLP-1 Drugs Powered IHE's Big Year. IXJ Is Playing a Longer Game.
11:17am, Wednesday, 27'th May 2026
A closer look at portfolio makeup, yield, and risk reveals what sets these two iShares healthcare funds apart for investors seeking sector exposure.
Ditch or Double Down on This Pharma ETF as Trump Adjusts Drug Prices?
04:19pm, Tuesday, 19'th May 2026
The iShares U.S. Pharmaceuticals ETF (NYSEARCA:IHE) is the rare fund that has spent the past year being publicly threatened by the President of the United States and quietly outperforming nearly every
Trump to announce discount drug pricing expansion, White House official says
12:47pm, Monday, 18'th May 2026
U.S. President Donald Trump will announce a dramatic expansion of TrumpRx.gov, a government-backed website offering discounted prescription drugs under his administration's pricing deal, on Mond
IHE: Healthcare Dashboard For May
10:42am, Saturday, 16'th May 2026
The healthcare sector is undervalued based on historical averages, especially the healthcare equipment industry. iShares U.S. Pharmaceuticals ETF offers cap-weighted exposure to U.S. pharma, with 44%
The Silver Tsunami: Healthcare ETFs to Buy Amid Aging US Demographics
11:41am, Wednesday, 13'th May 2026
ETFs like XLV stand out as aging U.S. demographics fuel rising demand for healthcare, medical devices and senior-focused care.
Should You Invest in the iShares U.S. Pharmaceuticals ETF (IHE)?
07:21am, Monday, 11'th May 2026
The iShares U.S. Pharmaceuticals ETF (IHE) was launched on May 1, 2006, and is a passively managed exchange traded fund designed to offer broad exposure to the Healthcare - Pharma segment of the equit
Should You Invest in the Invesco Pharmaceuticals ETF (PJP)?
07:21am, Wednesday, 29'th Apr 2026
Designed to provide broad exposure to the Healthcare - Pharma segment of the equity market, the Invesco Pharmaceuticals ETF (PJP) is a passively managed exchange traded fund launched on June 23, 2005.
